Visoluten
Khavinson natural peptide complex derived from eye tissue — used for retinal degeneration, glaucoma support, and age-related visual decline prevention.
🔬 Mechanism of Action
Visoluten is a Khavinson Cytomax derived from ocular tissue, complementing Normoftal with a peptide profile optimized for anterior segment (lens, cornea, ciliary body) as well as retinal support.
Visoluten modulates: (1) alpha-crystallin chaperone activity in the lens — the protective mechanism against cataract-causing protein aggregation, (2) corneal epithelial stem cell markers (p63, ABCG2) for corneal regenerative capacity, (3) ciliary body aqueous humor production for balanced intraocular pressure, and (4) retinal ganglion cell neuroprotective pathways relevant to glaucoma prevention.
In Khavinson ophthalmic protocols, Visoluten is often combined with Normoftal — Visoluten for anterior segment (lens/cornea/IOP) and Normoftal for posterior segment (retina/RPE).
Source: PMID: 15677927
📜Background & History
Visoluten is the retinal/eye Cytomax extract, supporting photoreceptor and ganglion cell function.
🎯 Research Use Cases
- ✓Retinal health
- ✓Visual decline prevention
- ✓Glaucoma support
💉 Dosing Protocol
| Typical Dose | 1-2 capsules/day |
| Frequency | 1-2× daily for 10-30 day cycles |
| Half-Life | ~30 minutes (estimated) |
⚠️Safety & Considerations
Standard oral Cytomax capsule protocol. Often paired with Normoftal for comprehensive visual support.
⚡Interactions & Contraindications
Standard Cytomax capsule protocol.
🔗Synergies & Common Stacks
Visoluten + Normoftal = comprehensive eye health from two Cytomax extracts targeting different ocular tissues.